Share Price and Basic Stock Data
Last Updated: January 27, 2026, 9:16 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Phyto Chem (India) Ltd, operating in the agrochemicals and pesticides sector, reported a market capitalization of ₹11.6 Cr and a share price of ₹27.0. The company has faced fluctuating revenue trends, with sales recorded at ₹12.47 Cr in September 2022, declining to ₹0.64 Cr by June 2023, before rebounding to ₹7.21 Cr in September 2023. The trailing twelve months (TTM) revenue stood at ₹10.97 Cr, reflecting significant volatility in sales performance. Historical annual sales peaked at ₹59.11 Cr in March 2019, but fell to ₹26.76 Cr in March 2023 and are projected to continue declining, with ₹14.75 Cr expected for March 2024 and ₹14.08 Cr for March 2025. This trend indicates challenges in maintaining consistent revenue streams, possibly due to market competition or operational inefficiencies. The company’s operational performance is further emphasized by a low operating profit margin (OPM) of -10.09%, suggesting ongoing issues in cost management and pricing strategy in a competitive market environment.
Profitability and Efficiency Metrics
Phyto Chem reported a net profit of ₹-0.68 Cr, reflecting a challenging profitability landscape. The company’s operating profit fluctuated significantly, with a recorded operating profit of ₹2.50 Cr in September 2022, which plummeted to a loss of ₹1.27 Cr by June 2023. Notably, the operating profit margin (OPM) showed a stark decline to -198.44% in that same quarter, indicating severe operational inefficiencies. The return on equity (ROE) stood at 14.6%, while the return on capital employed (ROCE) was notably lower at 3.27%, suggesting that the company is not effectively utilizing its capital to generate returns. The interest coverage ratio (ICR) of 0.61x further illustrates financial strain, as the company struggles to cover its interest obligations. These metrics highlight the need for strategic operational improvements and cost control measures to enhance profitability.
Balance Sheet Strength and Financial Ratios
Phyto Chem’s balance sheet reflects a concerning financial position, with total borrowings amounting to ₹14.78 Cr against reserves of only ₹1.06 Cr. The debt-to-equity ratio stood at 2.47, indicating a high level of leverage that raises questions about financial stability. The company’s current ratio of 1.26 and quick ratio of 0.74 suggest a potential liquidity risk, as current assets may not be sufficient to cover short-term liabilities. Additionally, the book value per share decreased to ₹14.85 in March 2025, down from ₹24.68 in March 2023, indicating a reduction in shareholder equity. The enterprise value (EV) of ₹28.18 Cr reflects a valuation that may not be justified given the company’s operational challenges. The declining profitability ratios and increasing leverage necessitate a careful review of the company’s capital structure and operational strategies.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Phyto Chem indicates a stable promoter holding of 40.40%, while public shareholders account for 54.78%. Institutional investment remains minimal, with domestic institutional investors (DIIs) holding only 0.19%. This lack of institutional interest may reflect concerns regarding the company’s financial performance and operational challenges. The number of shareholders stood at 7,303, showing slight fluctuations over recent quarters, which could indicate limited investor confidence in the company’s growth prospects. The government’s stake, reported at 4.63%, may provide some stability, but the overall low institutional presence suggests that investors are wary of the company’s future. The consistent promoter holding may signal a commitment to the company, yet the lack of broader investor interest could hinder capital-raising efforts in the future.
Outlook, Risks, and Final Insight
Phyto Chem faces several risks, including its high debt levels, operational inefficiencies, and a volatile revenue stream. The company’s ability to improve its profitability and manage costs effectively will be critical in the coming quarters. Additionally, the agrochemical sector is characterized by intense competition, which may impact market share and pricing power. A potential positive scenario could involve operational restructuring and improved product offerings, leading to enhanced sales and profitability. Conversely, failure to address these issues may result in further financial deterioration and diminished investor confidence. The future trajectory of Phyto Chem will depend on its strategic initiatives, market conditions, and the overall economic environment in the agrochemical sector, which requires careful monitoring and proactive management to navigate successfully.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd | 4,555 Cr. | 1,056 | 2,114/1,045 | 11.3 | 487 | 0.57 % | 24.9 % | 22.3 % | 10.0 |
| Dharmaj Crop Guard Ltd | 730 Cr. | 216 | 391/165 | 15.0 | 131 | 0.00 % | 12.0 % | 9.28 % | 10.0 |
| Bhaskar Agrochemicals Ltd | 54.4 Cr. | 104 | 149/56.6 | 9.75 | 40.0 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
| Bhagiradha Chemicals & Industries Ltd | 2,604 Cr. | 203 | 331/198 | 98.3 | 54.9 | 0.07 % | 7.44 % | 4.91 % | 1.00 |
| Best Agrolife Ltd | 775 Cr. | 22.0 | 35.8/16.3 | 60.6 | 22.8 | 0.91 % | 12.9 % | 9.95 % | 1.00 |
| Industry Average | 10,322.45 Cr | 1,043.38 | 28.82 | 369.04 | 0.46% | 15.21% | 19.87% | 6.67 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12.47 | 7.88 | 5.00 | 0.64 | 7.21 | 6.51 | 0.45 | 4.61 | 4.37 | 3.65 | 1.46 | 1.50 | 4.36 |
| Expenses | 9.97 | 7.60 | 4.36 | 1.91 | 6.67 | 5.76 | 3.74 | 5.63 | 3.81 | 3.48 | 2.51 | 2.02 | 4.80 |
| Operating Profit | 2.50 | 0.28 | 0.64 | -1.27 | 0.54 | 0.75 | -3.29 | -1.02 | 0.56 | 0.17 | -1.05 | -0.52 | -0.44 |
| OPM % | 20.05% | 3.55% | 12.80% | -198.44% | 7.49% | 11.52% | -731.11% | -22.13% | 12.81% | 4.66% | -71.92% | -34.67% | -10.09% |
| Other Income | 0.03 | 0.06 | 0.07 | 0.15 | 0.01 | 0.07 | 2.09 | 0.01 | 0.01 | 1.94 | 0.51 | 0.40 | 0.31 |
| Interest | 0.46 | 0.48 | 0.66 | 0.56 | 0.63 | 0.44 | 0.42 | 0.38 | 0.38 | 0.52 | 0.57 | 0.33 | 0.35 |
| Depreciation | 0.10 | 0.10 | 0.10 | 0.08 | 0.08 | 0.10 | 0.09 | 0.08 | 0.08 | 0.08 | 0.08 | 0.09 | 0.09 |
| Profit before tax | 1.97 | -0.24 | -0.05 | -1.76 | -0.16 | 0.28 | -1.71 | -1.47 | 0.11 | 1.51 | -1.19 | -0.54 | -0.57 |
| Tax % | 0.00% | 29.17% | -360.00% | 0.00% | 0.00% | 0.00% | 0.00% | -0.68% | 0.00% | -0.66% | -3.36% | -9.26% | -1.75% |
| Net Profit | 1.98 | -0.31 | 0.12 | -1.76 | -0.16 | 0.29 | -1.71 | -1.47 | 0.11 | 1.52 | -1.16 | -0.48 | -0.56 |
| EPS in Rs | 4.60 | -0.72 | 0.28 | -4.09 | -0.37 | 0.67 | -3.98 | -3.42 | 0.26 | 3.53 | -2.70 | -1.12 | -1.30 |
Last Updated: December 29, 2025, 1:34 pm
Below is a detailed analysis of the quarterly data for Phyto Chem (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 4.36 Cr.. The value appears strong and on an upward trend. It has increased from 1.50 Cr. (Jun 2025) to 4.36 Cr., marking an increase of 2.86 Cr..
- For Expenses, as of Sep 2025, the value is 4.80 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.02 Cr. (Jun 2025) to 4.80 Cr., marking an increase of 2.78 Cr..
- For Operating Profit, as of Sep 2025, the value is -0.44 Cr.. The value appears strong and on an upward trend. It has increased from -0.52 Cr. (Jun 2025) to -0.44 Cr., marking an increase of 0.08 Cr..
- For OPM %, as of Sep 2025, the value is -10.09%. The value appears strong and on an upward trend. It has increased from -34.67% (Jun 2025) to -10.09%, marking an increase of 24.58%.
- For Other Income, as of Sep 2025, the value is 0.31 Cr.. The value appears to be declining and may need further review. It has decreased from 0.40 Cr. (Jun 2025) to 0.31 Cr., marking a decrease of 0.09 Cr..
- For Interest, as of Sep 2025, the value is 0.35 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.33 Cr. (Jun 2025) to 0.35 Cr., marking an increase of 0.02 Cr..
- For Depreciation, as of Sep 2025, the value is 0.09 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.09 Cr..
- For Profit before tax, as of Sep 2025, the value is -0.57 Cr.. The value appears to be declining and may need further review. It has decreased from -0.54 Cr. (Jun 2025) to -0.57 Cr., marking a decrease of 0.03 Cr..
- For Tax %, as of Sep 2025, the value is -1.75%. The value appears to be increasing, which may not be favorable. It has increased from -9.26% (Jun 2025) to -1.75%, marking an increase of 7.51%.
- For Net Profit, as of Sep 2025, the value is -0.56 Cr.. The value appears to be declining and may need further review. It has decreased from -0.48 Cr. (Jun 2025) to -0.56 Cr., marking a decrease of 0.08 Cr..
- For EPS in Rs, as of Sep 2025, the value is -1.30. The value appears to be declining and may need further review. It has decreased from -1.12 (Jun 2025) to -1.30, marking a decrease of 0.18.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:48 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 29.29 | 40.92 | 21.77 | 44.45 | 58.90 | 59.11 | 44.22 | 44.49 | 23.12 | 26.76 | 14.75 | 14.08 | 10.97 |
| Expenses | 26.32 | 38.27 | 20.24 | 41.58 | 56.75 | 56.68 | 42.30 | 42.28 | 21.70 | 24.16 | 18.02 | 15.42 | 12.81 |
| Operating Profit | 2.97 | 2.65 | 1.53 | 2.87 | 2.15 | 2.43 | 1.92 | 2.21 | 1.42 | 2.60 | -3.27 | -1.34 | -1.84 |
| OPM % | 10.14% | 6.48% | 7.03% | 6.46% | 3.65% | 4.11% | 4.34% | 4.97% | 6.14% | 9.72% | -22.17% | -9.52% | -16.77% |
| Other Income | -0.06 | 0.12 | 0.68 | 0.27 | 1.55 | 0.98 | 1.38 | 0.80 | 1.29 | 0.16 | 2.32 | 2.47 | 3.16 |
| Interest | 1.63 | 1.64 | 1.72 | 1.67 | 2.13 | 2.10 | 2.47 | 2.12 | 2.10 | 2.10 | 2.05 | 1.84 | 1.77 |
| Depreciation | 0.35 | 0.32 | 0.31 | 0.31 | 0.36 | 0.40 | 0.41 | 0.43 | 0.41 | 0.40 | 0.34 | 0.34 | 0.34 |
| Profit before tax | 0.93 | 0.81 | 0.18 | 1.16 | 1.21 | 0.91 | 0.42 | 0.46 | 0.20 | 0.26 | -3.34 | -1.05 | -0.79 |
| Tax % | 34.41% | 34.57% | 38.89% | 26.72% | 23.97% | 19.78% | -4.76% | -6.52% | -15.00% | 15.38% | -0.30% | -5.71% | |
| Net Profit | 0.61 | 0.54 | 0.12 | 0.85 | 0.92 | 0.73 | 0.45 | 0.49 | 0.23 | 0.22 | -3.33 | -0.99 | -0.68 |
| EPS in Rs | 1.42 | 1.26 | 0.28 | 1.98 | 2.14 | 1.70 | 1.05 | 1.14 | 0.53 | 0.51 | -7.74 | -2.30 | -1.59 |
| Dividend Payout % | 70.49% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -11.48% | -77.78% | 608.33% | 8.24% | -20.65% | -38.36% | 8.89% | -53.06% | -4.35% | -1613.64% | 70.27% |
| Change in YoY Net Profit Growth (%) | 0.00% | -66.30% | 686.11% | -600.10% | -28.89% | -17.70% | 47.25% | -61.95% | 48.71% | -1609.29% | 1683.91% |
Phyto Chem (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -10% |
| 5 Years: | -20% |
| 3 Years: | -15% |
| TTM: | -42% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 100% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 4% |
| 3 Years: | 15% |
| 1 Year: | -5% |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -8% |
| 3 Years: | -16% |
| Last Year: | -14% |
Last Updated: September 5, 2025, 12:30 pm
Balance Sheet
Last Updated: December 4, 2025, 1:49 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 |
| Reserves | 3.12 | 3.48 | 3.60 | 4.00 | 4.52 | 5.12 | 5.55 | 5.88 | 6.15 | 6.31 | 3.06 | 2.09 | 1.06 |
| Borrowings | 14.22 | 16.00 | 16.04 | 18.46 | 18.55 | 22.08 | 22.98 | 21.37 | 21.23 | 19.47 | 18.19 | 15.77 | 14.78 |
| Other Liabilities | 10.53 | 11.92 | 5.63 | 15.24 | 30.31 | 41.46 | 34.87 | 13.91 | 6.78 | 9.94 | 6.16 | 5.72 | 4.91 |
| Total Liabilities | 32.17 | 35.70 | 29.57 | 42.00 | 57.68 | 72.96 | 67.70 | 45.46 | 38.46 | 40.02 | 31.71 | 27.88 | 25.05 |
| Fixed Assets | 4.21 | 3.68 | 3.50 | 3.25 | 4.10 | 4.18 | 4.67 | 3.43 | 3.13 | 2.75 | 2.74 | 2.39 | 2.23 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.32 | 0.32 | 0.32 | 0.24 | 0.25 | 0.12 | 0.11 | 0.16 | 0.17 | 0.07 | 0.08 | 0.05 | 0.07 |
| Other Assets | 27.64 | 31.70 | 25.75 | 38.51 | 53.24 | 68.21 | 62.92 | 41.87 | 35.16 | 37.20 | 28.89 | 25.44 | 22.75 |
| Total Assets | 32.17 | 35.70 | 29.57 | 42.00 | 57.68 | 72.96 | 67.70 | 45.46 | 38.46 | 40.02 | 31.71 | 27.88 | 25.05 |
Below is a detailed analysis of the balance sheet data for Phyto Chem (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 4.30 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.30 Cr..
- For Reserves, as of Sep 2025, the value is 1.06 Cr.. The value appears to be declining and may need further review. It has decreased from 2.09 Cr. (Mar 2025) to 1.06 Cr., marking a decrease of 1.03 Cr..
- For Borrowings, as of Sep 2025, the value is 14.78 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 15.77 Cr. (Mar 2025) to 14.78 Cr., marking a decrease of 0.99 Cr..
- For Other Liabilities, as of Sep 2025, the value is 4.91 Cr.. The value appears to be improving (decreasing). It has decreased from 5.72 Cr. (Mar 2025) to 4.91 Cr., marking a decrease of 0.81 Cr..
- For Total Liabilities, as of Sep 2025, the value is 25.05 Cr.. The value appears to be improving (decreasing). It has decreased from 27.88 Cr. (Mar 2025) to 25.05 Cr., marking a decrease of 2.83 Cr..
- For Fixed Assets, as of Sep 2025, the value is 2.23 Cr.. The value appears to be declining and may need further review. It has decreased from 2.39 Cr. (Mar 2025) to 2.23 Cr., marking a decrease of 0.16 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.07 Cr.. The value appears strong and on an upward trend. It has increased from 0.05 Cr. (Mar 2025) to 0.07 Cr., marking an increase of 0.02 Cr..
- For Other Assets, as of Sep 2025, the value is 22.75 Cr.. The value appears to be declining and may need further review. It has decreased from 25.44 Cr. (Mar 2025) to 22.75 Cr., marking a decrease of 2.69 Cr..
- For Total Assets, as of Sep 2025, the value is 25.05 Cr.. The value appears to be declining and may need further review. It has decreased from 27.88 Cr. (Mar 2025) to 25.05 Cr., marking a decrease of 2.83 Cr..
However, the Borrowings (14.78 Cr.) are higher than the Reserves (1.06 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -11.25 | -13.35 | -14.51 | -15.59 | -16.40 | -19.65 | -21.06 | -19.16 | -19.81 | -16.87 | -21.46 | -17.11 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 209.73 | 155.83 | 247.97 | 212.84 | 234.37 | 306.89 | 360.30 | 182.87 | 317.01 | 275.66 | 388.26 | 369.41 |
| Inventory Days | 167.93 | 159.73 | 260.64 | 133.35 | 115.59 | 128.58 | 182.77 | 172.49 | 342.41 | 314.83 | 373.42 | 338.21 |
| Days Payable | 99.24 | 113.43 | 86.08 | 135.72 | 176.25 | 283.01 | 338.07 | 110.32 | 41.10 | 122.87 | 91.09 | 91.75 |
| Cash Conversion Cycle | 278.42 | 202.12 | 422.53 | 210.47 | 173.71 | 152.46 | 205.00 | 245.04 | 618.32 | 467.62 | 670.59 | 615.87 |
| Working Capital Days | 59.32 | 48.26 | 103.95 | 53.62 | 43.75 | 45.14 | 69.58 | 85.08 | 155.35 | 150.45 | 161.34 | 129.88 |
| ROCE % | 13.06% | 12.02% | 7.75% | 11.16% | 12.34% | 10.16% | 8.98% | 6.96% | 7.28% | 7.55% | -4.93% | 3.27% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -2.31 | -7.75 | 0.52 | 0.53 | 1.15 |
| Diluted EPS (Rs.) | -2.31 | -7.75 | 0.52 | 0.53 | 1.15 |
| Cash EPS (Rs.) | -1.52 | -6.95 | 1.44 | 1.49 | 2.14 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 14.85 | 17.11 | 24.68 | 24.31 | 23.68 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 14.85 | 17.11 | 24.68 | 24.31 | 23.68 |
| Revenue From Operations / Share (Rs.) | 32.74 | 34.44 | 62.23 | 53.76 | 103.46 |
| PBDIT / Share (Rs.) | 2.62 | -2.20 | 6.42 | 6.28 | 7.00 |
| PBIT / Share (Rs.) | 1.84 | -3.00 | 5.50 | 5.33 | 6.01 |
| PBT / Share (Rs.) | -2.44 | -7.76 | 0.61 | 0.45 | 1.08 |
| Net Profit / Share (Rs.) | -2.31 | -7.75 | 0.51 | 0.53 | 1.15 |
| PBDIT Margin (%) | 8.01 | -6.39 | 10.31 | 11.68 | 6.76 |
| PBIT Margin (%) | 5.62 | -8.70 | 8.83 | 9.91 | 5.80 |
| PBT Margin (%) | -7.44 | -22.54 | 0.98 | 0.85 | 1.04 |
| Net Profit Margin (%) | -7.04 | -22.48 | 0.83 | 0.99 | 1.10 |
| Return on Networth / Equity (%) | -15.52 | -45.25 | 2.09 | 2.19 | 4.84 |
| Return on Capital Employeed (%) | 9.59 | -12.59 | 16.06 | 16.83 | 17.57 |
| Return On Assets (%) | -3.55 | -10.50 | 0.55 | 0.60 | 1.09 |
| Long Term Debt / Equity (X) | 0.16 | 0.23 | 0.26 | 0.22 | 0.35 |
| Total Debt / Equity (X) | 2.47 | 2.47 | 1.83 | 1.88 | 1.89 |
| Asset Turnover Ratio (%) | 0.47 | 0.41 | 0.68 | 0.55 | 0.78 |
| Current Ratio (X) | 1.26 | 1.31 | 1.44 | 1.40 | 1.35 |
| Quick Ratio (X) | 0.74 | 0.75 | 0.85 | 0.88 | 0.81 |
| Inventory Turnover Ratio (X) | 1.28 | 1.11 | 1.31 | 0.94 | 2.24 |
| Interest Coverage Ratio (X) | 0.61 | -0.46 | 1.31 | 1.29 | 1.42 |
| Interest Coverage Ratio (Post Tax) (X) | 0.46 | -0.62 | 1.11 | 1.11 | 1.23 |
| Enterprise Value (Cr.) | 28.18 | 31.77 | 33.51 | 28.18 | 26.50 |
| EV / Net Operating Revenue (X) | 2.00 | 2.15 | 1.25 | 1.22 | 0.59 |
| EV / EBITDA (X) | 24.97 | -33.54 | 12.14 | 10.43 | 8.81 |
| MarketCap / Net Operating Revenue (X) | 0.88 | 0.92 | 0.52 | 0.37 | 0.16 |
| Price / BV (X) | 1.95 | 1.87 | 1.33 | 0.83 | 0.72 |
| Price / Net Operating Revenue (X) | 0.88 | 0.92 | 0.52 | 0.37 | 0.16 |
| EarningsYield | -0.07 | -0.24 | 0.01 | 0.02 | 0.06 |
After reviewing the key financial ratios for Phyto Chem (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -2.31. This value is below the healthy minimum of 5. It has increased from -7.75 (Mar 24) to -2.31, marking an increase of 5.44.
- For Diluted EPS (Rs.), as of Mar 25, the value is -2.31. This value is below the healthy minimum of 5. It has increased from -7.75 (Mar 24) to -2.31, marking an increase of 5.44.
- For Cash EPS (Rs.), as of Mar 25, the value is -1.52. This value is below the healthy minimum of 3. It has increased from -6.95 (Mar 24) to -1.52, marking an increase of 5.43.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.85. It has decreased from 17.11 (Mar 24) to 14.85, marking a decrease of 2.26.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.85. It has decreased from 17.11 (Mar 24) to 14.85, marking a decrease of 2.26.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 32.74. It has decreased from 34.44 (Mar 24) to 32.74, marking a decrease of 1.70.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.62. This value is within the healthy range. It has increased from -2.20 (Mar 24) to 2.62, marking an increase of 4.82.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.84. This value is within the healthy range. It has increased from -3.00 (Mar 24) to 1.84, marking an increase of 4.84.
- For PBT / Share (Rs.), as of Mar 25, the value is -2.44. This value is below the healthy minimum of 0. It has increased from -7.76 (Mar 24) to -2.44, marking an increase of 5.32.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -2.31. This value is below the healthy minimum of 2. It has increased from -7.75 (Mar 24) to -2.31, marking an increase of 5.44.
- For PBDIT Margin (%), as of Mar 25, the value is 8.01. This value is below the healthy minimum of 10. It has increased from -6.39 (Mar 24) to 8.01, marking an increase of 14.40.
- For PBIT Margin (%), as of Mar 25, the value is 5.62. This value is below the healthy minimum of 10. It has increased from -8.70 (Mar 24) to 5.62, marking an increase of 14.32.
- For PBT Margin (%), as of Mar 25, the value is -7.44. This value is below the healthy minimum of 10. It has increased from -22.54 (Mar 24) to -7.44, marking an increase of 15.10.
- For Net Profit Margin (%), as of Mar 25, the value is -7.04. This value is below the healthy minimum of 5. It has increased from -22.48 (Mar 24) to -7.04, marking an increase of 15.44.
- For Return on Networth / Equity (%), as of Mar 25, the value is -15.52. This value is below the healthy minimum of 15. It has increased from -45.25 (Mar 24) to -15.52, marking an increase of 29.73.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.59. This value is below the healthy minimum of 10. It has increased from -12.59 (Mar 24) to 9.59, marking an increase of 22.18.
- For Return On Assets (%), as of Mar 25, the value is -3.55. This value is below the healthy minimum of 5. It has increased from -10.50 (Mar 24) to -3.55, marking an increase of 6.95.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.16. This value is below the healthy minimum of 0.2. It has decreased from 0.23 (Mar 24) to 0.16, marking a decrease of 0.07.
- For Total Debt / Equity (X), as of Mar 25, the value is 2.47. This value exceeds the healthy maximum of 1. There is no change compared to the previous period (Mar 24) which recorded 2.47.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.47. It has increased from 0.41 (Mar 24) to 0.47, marking an increase of 0.06.
- For Current Ratio (X), as of Mar 25, the value is 1.26. This value is below the healthy minimum of 1.5. It has decreased from 1.31 (Mar 24) to 1.26, marking a decrease of 0.05.
- For Quick Ratio (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 0.75 (Mar 24) to 0.74, marking a decrease of 0.01.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.28. This value is below the healthy minimum of 4. It has increased from 1.11 (Mar 24) to 1.28, marking an increase of 0.17.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.61. This value is below the healthy minimum of 3. It has increased from -0.46 (Mar 24) to 0.61, marking an increase of 1.07.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 3. It has increased from -0.62 (Mar 24) to 0.46, marking an increase of 1.08.
- For Enterprise Value (Cr.), as of Mar 25, the value is 28.18. It has decreased from 31.77 (Mar 24) to 28.18, marking a decrease of 3.59.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.00. This value is within the healthy range. It has decreased from 2.15 (Mar 24) to 2.00, marking a decrease of 0.15.
- For EV / EBITDA (X), as of Mar 25, the value is 24.97. This value exceeds the healthy maximum of 15. It has increased from -33.54 (Mar 24) to 24.97, marking an increase of 58.51.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 1. It has decreased from 0.92 (Mar 24) to 0.88, marking a decrease of 0.04.
- For Price / BV (X), as of Mar 25, the value is 1.95. This value is within the healthy range. It has increased from 1.87 (Mar 24) to 1.95, marking an increase of 0.08.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 1. It has decreased from 0.92 (Mar 24) to 0.88, marking a decrease of 0.04.
- For EarningsYield, as of Mar 25, the value is -0.07. This value is below the healthy minimum of 5. It has increased from -0.24 (Mar 24) to -0.07, marking an increase of 0.17.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Phyto Chem (India) Ltd:
- Net Profit Margin: -7.04%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.59% (Industry Average ROCE: 15.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -15.52% (Industry Average ROE: 19.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.46
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.74
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 28.82)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 2.47
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -7.04%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agro Chemicals/Pesticides | Survey No.628, Temple Street, Sangareddy Dist. Telangana 502313 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Dr. P Sreemannarayana | Chairman |
| Mr. Y Nayudamma | Managing Director |
| Mr. Y Janaki Ramaiah | Executive Director |
| Mr. S Y Sampath Kumar | Independent Director |
| Dr. M Sreerama Murthy | Independent Director |
| Mrs. G Vijitha | Independent Director |
| Mr. N Nagendra Naidu | Independent Director |
| Mr. N Sudhaka | Addnl.Non Exe.Independent Director |
| Mr. Y Sreemannarayana | Addnl.Non Exe.Independent Director |
| Mr. K Srinivasa Rao | Additional Non Exe.Non Ind.Director |
FAQ
What is the intrinsic value of Phyto Chem (India) Ltd?
Phyto Chem (India) Ltd's intrinsic value (as of 27 January 2026) is ₹17.79 which is 35.54% lower the current market price of ₹27.60, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹11.9 Cr. market cap, FY2025-2026 high/low of ₹39.9/24.5, reserves of ₹1.06 Cr, and liabilities of ₹25.05 Cr.
What is the Market Cap of Phyto Chem (India) Ltd?
The Market Cap of Phyto Chem (India) Ltd is 11.9 Cr..
What is the current Stock Price of Phyto Chem (India) Ltd as on 27 January 2026?
The current stock price of Phyto Chem (India) Ltd as on 27 January 2026 is ₹27.6.
What is the High / Low of Phyto Chem (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Phyto Chem (India) Ltd stocks is ₹39.9/24.5.
What is the Stock P/E of Phyto Chem (India) Ltd?
The Stock P/E of Phyto Chem (India) Ltd is .
What is the Book Value of Phyto Chem (India) Ltd?
The Book Value of Phyto Chem (India) Ltd is 12.5.
What is the Dividend Yield of Phyto Chem (India) Ltd?
The Dividend Yield of Phyto Chem (India) Ltd is 0.00 %.
What is the ROCE of Phyto Chem (India) Ltd?
The ROCE of Phyto Chem (India) Ltd is 3.27 %.
What is the ROE of Phyto Chem (India) Ltd?
The ROE of Phyto Chem (India) Ltd is 14.6 %.
What is the Face Value of Phyto Chem (India) Ltd?
The Face Value of Phyto Chem (India) Ltd is 10.0.